Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany

Objective: To compare the treatment costs of insulin glargine (IG; Lantus(®)) to detemir (ID; Levemir(®)), both combined with bolus insulin aspart (NovoRapid(®)) in type 2 diabetes (T2D) in Germany. Methods: Cost comparison was based on data of a 1-year randomised controlled trial [1]. IG was admini...

Descripción completa

Detalles Bibliográficos
Autores principales: Pscherer, Stefan, Dietrich, Eva Susanne, Dippel, Franz-Werner, Neilson, Aileen Rae
Formato: Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921814/
https://www.ncbi.nlm.nih.gov/pubmed/20725588
http://dx.doi.org/10.3205/000106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921814/
https://www.ncbi.nlm.nih.gov/pubmed/20725588
http://dx.doi.org/10.3205/000106

Ejemplares similares